AMAN U BUZDAR's research topics

AMAN U BUZDAR

Concepts (752)

Back to Profile

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name	Number of Publications	Most Recent Publication	Publications by All Authors	Concept Score	Why?
Aromatase Inhibitors	74	2021	305	9.890	Why?
Breast Neoplasms	530	2022	15694	9.380	Why?
Antineoplastic Agents, Hormonal	88	2020	840	8.820	Why?
Triazoles	80	2014	617	8.300	Why?
Nitriles	80	2014	906	8.190	Why?
Tamoxifen	107	2013	876	7.090	Why?
Postmenopause	66	2020	378	3.600	Why?
Antineoplastic Combined Chemotherapy Protocols	206	2022	15862	3.280	Why?
Neoplasms, Hormone-Dependent	35	2012	342	2.850	Why?
Chemotherapy, Adjuvant	112	2019	3890	2.770	Why?
Estrogen Antagonists	23	2013	184	2.610	Why?
Enzyme Inhibitors	31	2004	1879	2.580	Why?
Paclitaxel	56	2019	1996	2.420	Why?
Estradiol	20	2021	748	2.390	Why?
Receptor, ErbB-2	39	2019	2518	2.180	Why?
Neoadjuvant Therapy	61	2022	4975	2.140	Why?
Androstadienes	15	2013	165	2.080	Why?
Receptors, Estrogen	64	2019	2086	1.830	Why?
Antineoplastic Agents	94	2016	14289	1.790	Why?
Doxorubicin	131	2017	3005	1.740	Why?
Fluorouracil	107	2019	1944	1.650	Why?
Estrogen Receptor Modulators	10	2011	112	1.590	Why?
Cyclophosphamide	113	2019	3001	1.550	Why?
Female	503	2022	141928	1.440	Why?
Clinical Trials as Topic	80	2017	3719	1.430	Why?
Antineoplastic Agents, Phytogenic	23	2013	852	1.300	Why?
Selective Estrogen Receptor Modulators	6	2013	145	1.180	Why?
Humans	555	2022	261506	1.100	Why?
Receptors, Progesterone	20	2017	1392	1.050	Why?
Epirubicin	12	2019	157	1.020	Why?
Disease-Free Survival	78	2018	10001	1.010	Why?
Neoplasm Recurrence, Local	65	2021	10035	1.000	Why?
Middle Aged	351	2021	86204	0.990	Why?
Neoplasm Metastasis	111	2018	5112	0.910	Why?
Mastectomy	44	2014	1534	0.870	Why?
Trastuzumab	20	2019	696	0.870	Why?
Carcinoma, Intraductal, Noninfiltrating	11	2014	674	0.850	Why?
Anthracyclines	9	2016	331	0.830	Why?
Aged	259	2019	70117	0.810	Why?
Adult	275	2021	77950	0.770	Why?
Drug Administration Schedule	49	2019	3472	0.760	Why?
Megestrol Acetate	9	2004	29	0.740	Why?
Anticarcinogenic Agents	3	2013	362	0.740	Why?
Antibodies, Monoclonal	20	2011	4367	0.710	Why?
Thiophenes	3	2007	148	0.680	Why?
Taxoids	16	2013	967	0.680	Why?
Carcinoma	27	2006	2578	0.670	Why?
Neoplasm Staging	83	2016	13658	0.640	Why?
Double-Blind Method	25	2011	2588	0.630	Why?
Lymphatic Metastasis	56	2014	4844	0.630	Why?
Treatment Outcome	91	2018	32848	0.610	Why?
Breast Neoplasms, Male	8	2005	229	0.600	Why?
Antibiotics, Antineoplastic	15	2005	726	0.600	Why?
Combined Modality Therapy	74	2012	8865	0.590	Why?
Biomarkers, Tumor	22	2019	10331	0.560	Why?
Aromatase	6	2020	56	0.560	Why?
Piperidines	4	2007	1035	0.550	Why?
Survival Analysis	54	2016	9180	0.530	Why?
Time Factors	57	2019	12926	0.520	Why?
Antibodies, Monoclonal, Humanized	19	2013	3251	0.510	Why?
Megestrol	5	1998	15	0.510	Why?
Follow-Up Studies	73	2016	14889	0.500	Why?
Goserelin	2	2012	18	0.470	Why?
Randomized Controlled Trials as Topic	24	2012	2594	0.460	Why?
Survival Rate	47	2017	12221	0.430	Why?
Prognosis	92	2017	21713	0.430	Why?
Joint Diseases	2	2009	71	0.410	Why?
Premenopause	8	2013	131	0.410	Why?
Lymph Nodes	21	2014	2967	0.400	Why?
Vinblastine	20	2003	453	0.400	Why?
Dose-Response Relationship, Drug	28	2011	4938	0.360	Why?
Drug Resistance, Neoplasm	18	2020	5178	0.350	Why?
Angiogenesis Inhibitors	3	2012	1248	0.350	Why?
Mastectomy, Segmental	14	2011	1026	0.350	Why?
BCG Vaccine	27	1986	399	0.340	Why?
Niacinamide	1	2011	421	0.340	Why?
Drug Delivery Systems	1	2013	669	0.330	Why?
Biological Therapy	1	2009	58	0.330	Why?
Neoplasms, Second Primary	7	2016	1350	0.320	Why?
Tubulin Modulators	1	2008	65	0.320	Why?
Epothilones	1	2008	54	0.310	Why?
Mammography	6	2013	1010	0.310	Why?
Aged, 80 and over	42	2016	29902	0.310	Why?
Carcinoma, Ductal, Breast	9	2014	1216	0.310	Why?
Vascular Endothelial Growth Factor A	2	2011	1533	0.300	Why?
Deoxycytidine	5	2018	1353	0.300	Why?
Gene Amplification	3	2006	731	0.290	Why?
Aminoglutethimide	6	1997	12	0.290	Why?
Puerto Rico	2	2019	65	0.290	Why?
Endometrium	3	2005	470	0.280	Why?
Retrospective Studies	66	2022	37905	0.280	Why?
Polymorphism, Single Nucleotide	8	2021	4549	0.280	Why?
Medical Oncology	4	2013	1423	0.280	Why?
Prospective Studies	39	2017	12873	0.280	Why?
Diet, Fat-Restricted	1	2006	56	0.270	Why?
DNA Topoisomerases, Type II	1	2006	116	0.270	Why?
Cardiovascular Diseases	2	2011	2195	0.270	Why?
Drug Therapy, Combination	44	2006	2315	0.270	Why?
Gonadotropin-Releasing Hormone	4	2001	167	0.260	Why?
Quinazolines	3	2016	923	0.260	Why?
ErbB Receptors	3	2007	2295	0.260	Why?
Indoles	1	2011	1009	0.260	Why?
Estrone	4	2021	31	0.260	Why?
Mitomycins	9	1992	48	0.250	Why?
Neoplasm Invasiveness	8	2006	3981	0.250	Why?
Hormone Antagonists	1	2004	101	0.250	Why?
Disease Progression	12	2019	6682	0.240	Why?
Proportional Hazards Models	20	2016	4988	0.240	Why?
Multicenter Studies as Topic	6	2008	543	0.240	Why?
Obesity	5	2016	2884	0.240	Why?
Kaplan-Meier Estimate	9	2018	6207	0.240	Why?
Evidence-Based Medicine	4	2011	1085	0.240	Why?
Risk Factors	23	2019	17523	0.230	Why?
Fadrozole	3	2001	7	0.230	Why?
Neoplasm, Residual	10	2017	1656	0.230	Why?
Adenocarcinoma	11	2001	7789	0.230	Why?
Methotrexate	26	2003	999	0.220	Why?
United States	20	2019	15433	0.220	Why?
Antimetabolites, Antineoplastic	5	2004	1299	0.210	Why?
Capecitabine	4	2012	388	0.210	Why?
Toremifene	2	1998	8	0.210	Why?
Drug Tolerance	6	2006	114	0.200	Why?
Ki-67 Antigen	5	2013	666	0.200	Why?
Drug Design	1	2004	375	0.200	Why?
Axilla	17	2007	902	0.190	Why?
Nausea	9	2001	525	0.190	Why?
Decision Support Techniques	1	2005	622	0.180	Why?
Risk Assessment	13	2017	6869	0.180	Why?
Pregnancy Complications, Neoplastic	3	2004	222	0.180	Why?
Vomiting	8	2001	354	0.180	Why?
Guanidines	3	1995	60	0.180	Why?
Estrogens	6	2014	751	0.180	Why?
Forecasting	5	2007	694	0.180	Why?
Adjuvants, Pharmaceutic	1	1999	22	0.180	Why?
Antigens, Neoplasm	1	2006	1506	0.170	Why?
Remission Induction	15	2008	3569	0.170	Why?
Patient Selection	11	2017	2055	0.170	Why?
Alkaline Phosphatase	2	2019	207	0.170	Why?
Epistasis, Genetic	1	2019	119	0.170	Why?
Age Factors	15	2016	5377	0.160	Why?
DNA-Binding Proteins	2	2013	4821	0.160	Why?
Granulocyte Colony-Stimulating Factor	4	2011	749	0.150	Why?
Physical Examination	5	2006	299	0.150	Why?
Heart Failure	10	2011	2516	0.150	Why?
Drug Evaluation	21	1991	425	0.150	Why?
Peptichemio	5	1984	12	0.150	Why?
Carcinoma, Lobular	5	2007	611	0.150	Why?
Gene Expression Profiling	5	2011	5159	0.150	Why?
Antibodies, Anti-Idiotypic	2	1995	101	0.150	Why?
Multivariate Analysis	14	2009	4298	0.150	Why?
Quinolones	1	2018	160	0.150	Why?
Signal Transduction	6	2016	11965	0.140	Why?
Genes, erbB-2	2	2010	229	0.140	Why?
Incidence	14	2007	5673	0.140	Why?
Postoperative Care	6	2014	739	0.140	Why?
Stroke Volume	4	2013	577	0.140	Why?
Risk	7	2016	1972	0.140	Why?
Menopause	14	1998	159	0.140	Why?
Practice Patterns, Physicians'	1	2005	1303	0.140	Why?
Probability	7	2005	866	0.140	Why?
Fluorine Radioisotopes	4	1997	133	0.130	Why?
Genetic Predisposition to Disease	2	2021	5539	0.130	Why?
Immunologic Factors	1	1999	649	0.130	Why?
Promethazine	1	1994	7	0.130	Why?
Lorazepam	1	1994	40	0.120	Why?
TOR Serine-Threonine Kinases	2	2013	1546	0.120	Why?
Inflammation	10	2007	2522	0.120	Why?
Preoperative Care	6	2008	1529	0.120	Why?
Confidence Intervals	6	2008	756	0.120	Why?
Administration, Oral	11	2010	1544	0.120	Why?
Bone Neoplasms	16	2007	2576	0.120	Why?
Drug Eruptions	3	1996	256	0.120	Why?
Antibodies, Neoplasm	2	1997	259	0.120	Why?
Carcinoembryonic Antigen	3	2000	222	0.120	Why?
Carcinoma in Situ	3	2010	487	0.120	Why?
Therapeutic Equivalency	3	2002	49	0.120	Why?
Women's Health	3	2013	205	0.120	Why?
Odds Ratio	6	2016	2316	0.120	Why?
Alkaloids	2	1991	75	0.120	Why?
Liver Neoplasms	12	2000	4557	0.110	Why?
Genome-Wide Association Study	5	2021	2265	0.110	Why?
Melphalan	4	1987	834	0.110	Why?
Neoplasms	7	2017	15193	0.110	Why?
Foot Diseases	1	1993	52	0.110	Why?
Nail Diseases	1	1993	40	0.110	Why?
Blood Proteins	3	2010	294	0.110	Why?
Overweight	1	2016	484	0.110	Why?
Vincristine	15	2001	1511	0.110	Why?
Genetic Association Studies	2	2017	1084	0.110	Why?
Oligonucleotides	2	2011	227	0.110	Why?
Patient Advocacy	1	1992	92	0.110	Why?
Tomography, Emission-Computed	4	1997	310	0.110	Why?
Tumor Suppressor Proteins	1	2020	1823	0.110	Why?
Triple Negative Breast Neoplasms	1	2022	1215	0.110	Why?
Analysis of Variance	9	2009	2307	0.100	Why?
Cognition Disorders	2	2010	786	0.100	Why?
Random Allocation	14	1990	703	0.100	Why?
Bone Marrow Transplantation	5	2000	1581	0.100	Why?
Predictive Value of Tests	12	2007	4892	0.100	Why?
Regression Analysis	8	2014	1546	0.100	Why?
Cohort Studies	10	2016	9244	0.100	Why?
Prednisone	11	2001	984	0.100	Why?
North America	2	2002	314	0.100	Why?
Body Mass Index	5	2016	2203	0.100	Why?
Dexamethasone	2	2000	1450	0.100	Why?
Safety	2	2005	465	0.100	Why?
Bevacizumab	2	2012	938	0.090	Why?
Hormones	6	2005	266	0.090	Why?
Mitoxantrone	7	1999	216	0.090	Why?
Androstenedione	3	2014	18	0.090	Why?
Computer Simulation	1	2006	1529	0.090	Why?
Albumin-Bound Paclitaxel	1	2010	9	0.090	Why?
Ellipticines	1	1990	2	0.090	Why?
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization	1	2010	208	0.090	Why?
Treatment Failure	4	2007	1391	0.090	Why?
Gene Expression Regulation, Enzymologic	1	2013	703	0.090	Why?
Hematinics	1	2011	109	0.090	Why?
Antineoplastic Agents, Alkylating	4	2008	588	0.090	Why?
Membrane Proteins	1	2020	2819	0.090	Why?
Mitogen-Activated Protein Kinases	2	2004	639	0.090	Why?
Urokinase-Type Plasminogen Activator	1	1990	136	0.090	Why?
Clinical Trials, Phase III as Topic	3	2004	447	0.090	Why?
Vena Cava, Superior	1	1990	78	0.090	Why?
Neutropenia	6	2002	968	0.090	Why?
Immunotherapy	7	1999	3341	0.090	Why?
Heart	6	1997	1223	0.090	Why?
Biomedical Research	1	2016	806	0.090	Why?
Radiotherapy, Adjuvant	8	2014	2231	0.090	Why?
Hematopoietic Stem Cell Transplantation	7	2006	6550	0.080	Why?
Leukopenia	6	1985	151	0.080	Why?
Neoplasm Grading	1	2013	1742	0.080	Why?
Drug Hypersensitivity	2	1990	128	0.080	Why?
Young Adult	9	2015	21445	0.080	Why?
CA-125 Antigen	1	2000	226	0.080	Why?
SEER Program	4	2008	1000	0.080	Why?
Infusions, Intravenous	10	2010	1382	0.080	Why?
Biopsy, Needle	5	2004	1363	0.080	Why?
Survival	2	2013	177	0.080	Why?
Etoposide	7	2006	870	0.080	Why?
Tumor Suppressor Protein p53	3	2006	3552	0.080	Why?
HSP90 Heat-Shock Proteins	1	2009	196	0.080	Why?
Albumins	1	2010	258	0.080	Why?
Ultrasonography, Mammary	3	2006	380	0.080	Why?
Oligonucleotide Array Sequence Analysis	2	2006	2508	0.080	Why?
Estrogen Receptor alpha	2	2020	701	0.080	Why?
Nuclear Proteins	2	2013	3343	0.080	Why?
Collagen Type IV	1	2008	108	0.080	Why?
Research Design	4	2017	1544	0.080	Why?
Central Nervous System Neoplasms	2	2004	502	0.080	Why?
Thrombolytic Therapy	1	1990	257	0.080	Why?
Antineoplastic Agents, Immunological	1	2017	1249	0.080	Why?
Radiation-Sensitizing Agents	1	1990	363	0.080	Why?
Endpoint Determination	2	2012	176	0.080	Why?
Protein Kinase Inhibitors	2	2016	4757	0.080	Why?
Premedication	3	2004	135	0.080	Why?
Immunosuppressive Agents	1	1994	1375	0.080	Why?
Drug Approval	2	2012	178	0.080	Why?
Animals	11	2013	59536	0.070	Why?
In Situ Hybridization, Fluorescence	2	2016	2232	0.070	Why?
Neoplasms, Multiple Primary	2	1988	551	0.070	Why?
Peripheral Nervous System Diseases	3	2009	393	0.070	Why?
Drug Interactions	3	2008	553	0.070	Why?
Europe	3	2001	649	0.070	Why?
Actuarial Analysis	2	2001	159	0.070	Why?
Gene Expression	1	2015	3570	0.070	Why?
Lymph Node Excision	6	2000	1959	0.070	Why?
Male	33	2011	123000	0.070	Why?
Recurrence	6	2009	4758	0.070	Why?
Quality of Health Care	1	2011	621	0.070	Why?
Thalidomide	1	2000	569	0.070	Why?
Catheterization, Central Venous	1	1990	354	0.070	Why?
Drug Evaluation, Preclinical	1	2008	503	0.070	Why?
Carcinoma, Ductal	2	2005	145	0.070	Why?
Aminoacridines	3	1986	23	0.070	Why?
Lipids	2	2003	644	0.070	Why?
Receptors, Steroid	1	2007	286	0.070	Why?
CD40 Antigens	1	2007	104	0.070	Why?
Quality of Life	6	2015	4532	0.070	Why?
Neuralgia	1	2009	251	0.070	Why?
Tissue Array Analysis	1	2008	760	0.070	Why?
Cross-Over Studies	2	2004	460	0.070	Why?
Neoplasm Proteins	5	2021	3230	0.070	Why?
Thrombocytopenia	8	1991	846	0.070	Why?
Food-Drug Interactions	1	2005	22	0.070	Why?
Heart Diseases	4	1999	732	0.070	Why?
Tissue Fixation	1	2006	136	0.070	Why?
Gonadal Steroid Hormones	1	2006	110	0.070	Why?
Formaldehyde	1	2006	114	0.070	Why?
Genotype	4	2019	4109	0.070	Why?
Patient Care Management	1	2006	94	0.070	Why?
Fever	3	2002	497	0.070	Why?
Paraffin Embedding	1	2006	226	0.070	Why?
Protein Kinases	1	2009	874	0.070	Why?
RNA, Neoplasm	2	2003	771	0.060	Why?
Nanoparticles	1	2010	554	0.060	Why?
Anemia	1	2011	689	0.060	Why?
Blood Specimen Collection	1	2005	93	0.060	Why?
Organoplatinum Compounds	1	1987	702	0.060	Why?
Polyps	1	2005	74	0.060	Why?
Receptor Cross-Talk	1	2005	79	0.060	Why?
Mucin-1	1	2004	127	0.060	Why?
Controlled Clinical Trials as Topic	1	2004	32	0.060	Why?
Chromatography, High Pressure Liquid	1	2005	548	0.060	Why?
Thrombosis	2	1992	781	0.060	Why?
Estrogen Receptor beta	1	2005	155	0.060	Why?
Pregnancy, High-Risk	1	2004	49	0.060	Why?
Cancer Vaccines	1	2009	697	0.060	Why?
Area Under Curve	1	2005	700	0.060	Why?
Drug Resistance	7	1999	587	0.060	Why?
Texas	5	2007	6311	0.060	Why?
Data Interpretation, Statistical	1	2006	482	0.060	Why?
Celecoxib	1	2004	200	0.060	Why?
Health Care Costs	2	2011	674	0.060	Why?
Uterus	2	2005	678	0.060	Why?
Myelodysplastic Syndromes	1	2016	2979	0.060	Why?
Health Care Surveys	1	2005	430	0.060	Why?
Nomograms	1	2005	313	0.060	Why?
Diagnosis, Differential	7	2000	4744	0.060	Why?
Radionuclide Imaging	3	2000	660	0.060	Why?
Disease Management	2	2006	1052	0.060	Why?
Health Services	1	2003	105	0.060	Why?
Radiotherapy Dosage	7	2014	3842	0.060	Why?
Mass Spectrometry	1	2005	702	0.060	Why?
Pigmentation Disorders	2	1979	38	0.050	Why?
Quality-Adjusted Life Years	1	2003	226	0.050	Why?
Transplantation, Autologous	7	2006	1914	0.050	Why?
Mammary Neoplasms, Experimental	2	1998	494	0.050	Why?
National Cancer Institute (U.S.)	2	2017	211	0.050	Why?
Acanthosis Nigricans	1	1992	15	0.050	Why?
Radiography	3	2004	1904	0.050	Why?
Consensus	1	2006	978	0.050	Why?
Cholesterol, LDL	1	2006	565	0.050	Why?
Gene Expression Regulation, Neoplastic	5	2013	8873	0.050	Why?
Reproducibility of Results	4	2006	6009	0.050	Why?
Clinical Trials, Phase I as Topic	1	2005	604	0.050	Why?
Paraneoplastic Syndromes	1	1992	82	0.050	Why?
Leucovorin	4	1997	332	0.050	Why?
Endometrial Neoplasms	3	2005	1341	0.050	Why?
Cytochrome P-450 Enzyme System	1	2003	200	0.050	Why?
Genetic Testing	1	2010	1589	0.050	Why?
Colitis	1	2004	340	0.050	Why?
Cisplatin	7	2006	2432	0.050	Why?
Neuregulin-1	1	2001	83	0.050	Why?
Radiotherapy, High-Energy	2	1981	295	0.050	Why?
Metaplasia	1	2022	383	0.050	Why?
Education, Medical, Continuing	1	2003	251	0.050	Why?
Headache	1	2001	163	0.050	Why?
Remission, Spontaneous	12	1980	119	0.050	Why?
Severity of Illness Index	3	2003	4320	0.050	Why?
Sensitivity and Specificity	6	2006	4971	0.050	Why?
Genome, Human	2	2021	1869	0.050	Why?
Breast Self-Examination	1	2000	16	0.050	Why?
Sentinel Lymph Node Biopsy	2	2014	1415	0.050	Why?
Chemoprevention	1	2001	241	0.050	Why?
Mastectomy, Modified Radical	5	2007	70	0.050	Why?
Logistic Models	4	2009	3441	0.050	Why?
Tongue Diseases	1	1979	17	0.050	Why?
Genes, p53	1	2004	1090	0.050	Why?
Adolescent	13	2011	31252	0.040	Why?
Oropharynx	1	1979	74	0.040	Why?
Cost-Benefit Analysis	1	2003	945	0.040	Why?
Reverse Transcriptase Polymerase Chain Reaction	1	2006	3639	0.040	Why?
Smallpox Vaccine	1	1979	43	0.040	Why?
Neoplasms, Unknown Primary	1	2001	192	0.040	Why?
Pneumonia	2	2004	751	0.040	Why?
Transcription Factors	1	2013	5270	0.040	Why?
Rats	4	2005	6086	0.040	Why?
Enterocolitis, Pseudomembranous	1	2000	111	0.040	Why?
Pharmacogenetics	1	2020	260	0.040	Why?
Leukemia, Lymphoid	1	1979	276	0.040	Why?
Registries	3	2016	2170	0.040	Why?
Cricetinae	2	1998	706	0.040	Why?
Reference Values	3	2006	1099	0.040	Why?
Chromosomes, Human, Pair 2	1	2019	172	0.040	Why?
Pulmonary Fibrosis	1	1980	170	0.040	Why?
GPI-Linked Proteins	1	2019	223	0.040	Why?
Carcinoma, Papillary	1	1992	584	0.040	Why?
Ifosfamide	1	1979	344	0.040	Why?
Drug Resistance, Multiple	1	1999	204	0.040	Why?
Medical Records	3	2008	415	0.040	Why?
Models, Biological	3	2004	3254	0.040	Why?
MicroRNAs	1	2011	2947	0.040	Why?
Paraplegia	1	1978	95	0.040	Why?
Antigens, Tumor-Associated, Carbohydrate	1	1997	123	0.040	Why?
Medroxyprogesterone	2	1989	14	0.040	Why?
Mastectomy, Simple	3	1993	58	0.040	Why?
RNA, Messenger	3	2015	6150	0.040	Why?
Hematologic Diseases	3	1990	242	0.040	Why?
Immunohistochemistry	4	2013	7548	0.040	Why?
Heart Function Tests	1	1997	73	0.040	Why?
Carcinoma, Hepatocellular	1	2000	2027	0.040	Why?
Chromosomes, Human, Pair 16	1	2019	254	0.040	Why?
Interferon-alpha	2	1992	889	0.040	Why?
Testosterone	2	2014	619	0.040	Why?
Pregnanes	1	1997	5	0.040	Why?
Colorectal Neoplasms	2	2000	3578	0.040	Why?
Liver Diseases	2	1983	574	0.040	Why?
Diethylstilbestrol	1	1977	109	0.040	Why?
Practice Guidelines as Topic	1	2007	2403	0.040	Why?
DNA Adducts	1	1998	210	0.040	Why?
Immunoenzyme Techniques	4	2004	1165	0.040	Why?
INDEL Mutation	1	2017	112	0.040	Why?
Leukemia, Myeloid, Acute	1	2016	6915	0.040	Why?
Granuloma	1	1978	154	0.040	Why?
Ovariectomy	1	1998	330	0.040	Why?
Tumor Burden	2	2017	1987	0.040	Why?
Erythema Multiforme	1	1996	14	0.040	Why?
Castration	6	1983	122	0.040	Why?
Raloxifene Hydrochloride	2	2005	47	0.040	Why?
Insulin Resistance	1	1992	731	0.040	Why?
Ultrasonography	5	2001	1863	0.040	Why?
Antibody Formation	2	1995	383	0.030	Why?
Mediastinal Neoplasms	1	2000	423	0.030	Why?
Deoxyglucose	1	1996	115	0.030	Why?
Hyperbilirubinemia	1	1996	78	0.030	Why?
Cell Proliferation	2	2006	7226	0.030	Why?
Biopsy, Fine-Needle	2	2011	690	0.030	Why?
Cause of Death	2	2005	752	0.030	Why?
Tegafur	3	1988	50	0.030	Why?
Up-Regulation	2	2007	2450	0.030	Why?
9,10-Dimethyl-1,2-benzanthracene	2	2005	108	0.030	Why?
Clavicle	2	2001	65	0.030	Why?
Bridged-Ring Compounds	2	2007	183	0.030	Why?
Tissue Distribution	4	2005	875	0.030	Why?
Proto-Oncogene Proteins	1	2004	2488	0.030	Why?
Pyrazoles	1	2004	1471	0.030	Why?
Patient Care Planning	2	2011	297	0.030	Why?
Blood Cell Count	8	1996	225	0.030	Why?
Statistics, Nonparametric	3	2006	980	0.030	Why?
Lung Neoplasms	5	2002	11538	0.030	Why?
Sulfonamides	1	2004	1823	0.030	Why?
Polymerase Chain Reaction	2	2011	3203	0.030	Why?
Brain Diseases	1	1978	403	0.030	Why?
Pregnancy	4	2004	7573	0.030	Why?
Myocardial Infarction	1	2003	1374	0.030	Why?
Bacterial Vaccines	2	1987	103	0.030	Why?
Comorbidity	2	2011	2352	0.030	Why?
Cell Line, Tumor	4	2009	14551	0.030	Why?
Evaluation Studies as Topic	5	1997	418	0.030	Why?
Leukemia	4	1996	1635	0.030	Why?
Radiation Injuries	3	2006	1411	0.030	Why?
Rats, Sprague-Dawley	3	2005	2063	0.030	Why?
Paronychia	1	1993	4	0.030	Why?
Alopecia	5	1986	126	0.030	Why?
Nucleotide Motifs	1	2013	62	0.030	Why?
Neuropsychological Tests	2	2010	1178	0.030	Why?
Information Systems	3	1987	54	0.030	Why?
Toes	1	1993	46	0.030	Why?
Soft Tissue Neoplasms	6	2007	882	0.030	Why?
Liver Function Tests	3	1988	173	0.030	Why?
Protein Binding	2	2013	3438	0.030	Why?
Sleep Stages	2	1982	78	0.030	Why?
Liability, Legal	1	1992	48	0.030	Why?
Species Specificity	1	1994	777	0.030	Why?
Algorithms	3	2011	3890	0.030	Why?
Radiotherapy	2	2014	1824	0.030	Why?
Fingers	1	1993	120	0.030	Why?
Phenotype	2	2017	6295	0.030	Why?
Biomarkers	1	2004	5047	0.030	Why?
Insulin-Like Growth Factor Binding Protein 1	1	2011	29	0.030	Why?
Iodine Radioisotopes	1	1994	371	0.030	Why?
Thiotepa	3	1990	118	0.030	Why?
Chromosomes, Human, Pair 8	1	2013	317	0.030	Why?
Germ-Line Mutation	1	2017	1046	0.030	Why?
Chromatin Immunoprecipitation	1	2013	518	0.030	Why?
Clinical Trials, Phase II as Topic	1	1994	665	0.030	Why?
Apoptosis	1	2006	7591	0.030	Why?
Chi-Square Distribution	2	2007	1323	0.020	Why?
MCF-7 Cells	1	2013	550	0.020	Why?
Clinical Protocols	1	1994	467	0.020	Why?
Palliative Care	4	2002	2037	0.020	Why?
Autoradiography	2	2005	132	0.020	Why?
Insulin-Like Growth Factor Binding Protein 3	1	2011	153	0.020	Why?
Thyroid Neoplasms	1	1992	1866	0.020	Why?
Cardiomyopathies	2	1989	610	0.020	Why?
Levamisole	3	1979	12	0.020	Why?
Population Surveillance	1	2005	627	0.020	Why?
Postoperative Period	1	1993	665	0.020	Why?
p38 Mitogen-Activated Protein Kinases	2	2004	334	0.020	Why?
United States Food and Drug Administration	1	2012	332	0.020	Why?
Pain	2	1991	1658	0.020	Why?
Fractures, Bone	3	2008	291	0.020	Why?
Feasibility Studies	3	2001	2292	0.020	Why?
Antibody-Dependent Cell Cytotoxicity	1	2010	84	0.020	Why?
Neoplasm Regression, Spontaneous	2	1982	34	0.020	Why?
Canada	1	2001	429	0.020	Why?
Mice	4	2005	34495	0.020	Why?
DNA Copy Number Variations	1	2017	1516	0.020	Why?
Pseudomonas	2	1987	21	0.020	Why?
Ethinyl Estradiol	1	1989	15	0.020	Why?
Hypercalcemia	3	1996	137	0.020	Why?
Electrophoretic Mobility Shift Assay	1	2010	191	0.020	Why?
Bone Marrow	7	1984	2358	0.020	Why?
Benchmarking	1	2011	273	0.020	Why?
Liver	3	2005	2961	0.020	Why?
Databases, Factual	1	2016	2218	0.020	Why?
Preoperative Period	1	2010	344	0.020	Why?
Skin Diseases	2	1982	349	0.020	Why?
Chromatography, Liquid	1	2010	342	0.020	Why?
Mastectomy, Radical	2	2004	39	0.020	Why?
alpha-Fetoproteins	1	2000	237	0.020	Why?
Dihydrotestosterone	1	1989	118	0.020	Why?
Erythrocyte Transfusion	1	2011	212	0.020	Why?
Catheters, Indwelling	1	1992	374	0.020	Why?
Agranulocytosis	4	1994	79	0.020	Why?
Anthraquinones	2	1985	27	0.020	Why?
Insulin-Like Growth Factor I	1	2011	630	0.020	Why?
Interferons	2	1980	291	0.020	Why?
Amenorrhea	3	1990	34	0.020	Why?
Carboplatin	1	2011	823	0.020	Why?
Recombinant Fusion Proteins	1	1994	1555	0.020	Why?
Precision Medicine	1	2016	1154	0.020	Why?
Osteolysis	1	1988	80	0.020	Why?
Bronchial Neoplasms	2	1978	79	0.020	Why?
Likelihood Functions	1	2008	233	0.020	Why?
Age of Onset	2	2001	827	0.020	Why?
Ovary	2	2005	668	0.020	Why?
Arthralgia	1	2008	89	0.020	Why?
Meta-Analysis as Topic	1	1988	276	0.020	Why?
Case-Control Studies	2	2013	6100	0.020	Why?
Glycoproteins	1	1991	747	0.020	Why?
Drug-Related Side Effects and Adverse Reactions	1	2012	598	0.020	Why?
Staphylococcal Protein A	1	1987	18	0.020	Why?
Arthritis	1	2008	139	0.020	Why?
Hydrocortisone	1	1989	388	0.020	Why?
Secondary Prevention	1	2009	329	0.020	Why?
Environment, Controlled	1	1987	21	0.020	Why?
Methylcellulose	1	1986	9	0.020	Why?
Interferon Inducers	1	1986	9	0.020	Why?
Polylysine	1	1986	17	0.020	Why?
Osteoradionecrosis	1	1988	123	0.020	Why?
Poly I-C	1	1986	29	0.020	Why?
Carboxymethylcellulose Sodium	1	1986	18	0.020	Why?
Placebos	1	2008	437	0.020	Why?
Amsacrine	2	1986	61	0.020	Why?
Memory	1	2010	429	0.020	Why?
Patient Education as Topic	1	2011	748	0.020	Why?
Blood	1	1987	156	0.020	Why?
Analgesics	1	2009	390	0.020	Why?
Reoperation	1	2011	1382	0.020	Why?
Base Sequence	1	2013	4917	0.020	Why?
Methods	2	1990	189	0.020	Why?
Acute Disease	2	1990	2422	0.020	Why?
Anthracenes	2	1986	48	0.020	Why?
Bleomycin	1	1987	467	0.020	Why?
Phosphonoacetic Acid	1	1985	18	0.020	Why?
Decision Making, Computer-Assisted	1	2005	32	0.020	Why?
Congresses as Topic	1	2008	298	0.020	Why?
Carbon Radioisotopes	1	2005	116	0.020	Why?
France	1	2005	108	0.020	Why?
Promoter Regions, Genetic	1	2013	3101	0.020	Why?
Molecular Sequence Data	1	2013	6089	0.020	Why?
Pyrrolidines	1	1986	113	0.020	Why?
Health Services Accessibility	1	2011	761	0.020	Why?
Body Weight	2	2008	1293	0.020	Why?
Organophosphorus Compounds	1	1985	101	0.020	Why?
Electrocardiography	2	1983	1145	0.020	Why?
In Situ Nick-End Labeling	1	2006	448	0.020	Why?
Vinca Alkaloids	1	1985	9	0.020	Why?
Aspartic Acid	1	1985	126	0.020	Why?
Microarray Analysis	1	2006	392	0.020	Why?
Breast Diseases	1	1986	201	0.020	Why?
Hemorrhage	3	2001	712	0.020	Why?
Phlebitis	1	1984	8	0.020	Why?
Nipples	1	2005	132	0.020	Why?
Molecular Targeted Therapy	1	2015	2330	0.020	Why?
Models, Chemical	1	2005	186	0.020	Why?
Patient Acceptance of Health Care	1	2009	573	0.020	Why?
Membrane Glycoproteins	1	1989	1073	0.020	Why?
Flow Cytometry	1	2011	3033	0.020	Why?
Mitomycin	1	1985	208	0.020	Why?
Half-Life	1	2004	259	0.020	Why?
Patient Compliance	1	1988	667	0.020	Why?
Colonic Neoplasms	1	1992	1390	0.020	Why?
Bone Marrow Diseases	2	1984	177	0.010	Why?
Kinetics	1	2007	2049	0.010	Why?
Zinc Fingers	1	2004	205	0.010	Why?
Luciferases	1	2005	445	0.010	Why?
Climacteric	1	2003	3	0.010	Why?
Carcinogens	1	2005	384	0.010	Why?
Paralysis	1	1983	51	0.010	Why?
Skin Neoplasms	1	2000	4654	0.010	Why?
DNA	1	2011	2693	0.010	Why?
ROC Curve	1	2006	1183	0.010	Why?
Skull Neoplasms	1	1983	67	0.010	Why?
Dizziness	1	1982	47	0.010	Why?
Age Distribution	1	2004	698	0.010	Why?
Surveys and Questionnaires	1	2015	5687	0.010	Why?
Cranial Nerve Diseases	1	1983	73	0.010	Why?
Genes, Reporter	1	2005	798	0.010	Why?
Patient Care Team	1	2008	795	0.010	Why?
Statistics as Topic	1	2003	445	0.010	Why?
Biopsy	2	2000	3443	0.010	Why?
Neoplasms, Experimental	1	2005	750	0.010	Why?
Asparaginase	2	1980	184	0.010	Why?
Hemangiosarcoma	1	1984	234	0.010	Why?
Cobalt Radioisotopes	1	1981	42	0.010	Why?
Neoplasms, Radiation-Induced	1	1984	388	0.010	Why?
Neoplasm Transplantation	1	2005	1519	0.010	Why?
Proto-Oncogene Proteins c-mdm2	1	2004	507	0.010	Why?
Radiation Tolerance	1	2004	629	0.010	Why?
Internet	1	2005	706	0.010	Why?
Edema	1	1982	267	0.010	Why?
Skin Tests	1	1981	96	0.010	Why?
Ranitidine	1	2000	35	0.010	Why?
Transcriptional Activation	1	2005	1070	0.010	Why?
Thromboembolism	1	2001	155	0.010	Why?
Colonoscopy	1	2004	518	0.010	Why?
Immune Complex Diseases	1	1980	12	0.010	Why?
Altretamine	1	1979	4	0.010	Why?
Pregnancy Outcome	1	2004	643	0.010	Why?
Adrenal Cortex Hormones	2	1983	544	0.010	Why?
Radiation Dosage	1	2004	1014	0.010	Why?
Electrons	1	1981	168	0.010	Why?
Nitrogen Mustard Compounds	1	1980	73	0.010	Why?
Pharyngeal Diseases	1	1979	53	0.010	Why?
Carrier Proteins	1	1998	2022	0.010	Why?
Stomatitis	3	1989	183	0.010	Why?
Glomerulonephritis	1	1980	109	0.010	Why?
Frail Elderly	1	2000	118	0.010	Why?
Delphi Technique	1	2000	210	0.010	Why?
Mouth Mucosa	1	1979	216	0.010	Why?
Apgar Score	1	1999	55	0.010	Why?
Cell Nucleus	1	2004	1620	0.010	Why?
Triazines	1	1979	117	0.010	Why?
Chlorambucil	1	1978	26	0.010	Why?
Mucous Membrane	1	1979	271	0.010	Why?
Urticaria	1	1978	23	0.010	Why?
Nitrosourea Compounds	1	1978	12	0.010	Why?
Transcription, Genetic	1	2007	3154	0.010	Why?
Disease	1	2000	165	0.010	Why?
Cytarabine	1	1985	1973	0.010	Why?
Nails	1	1978	36	0.010	Why?
Lomustine	1	1978	39	0.010	Why?
Bacterial Infections	3	1992	479	0.010	Why?
Injections, Intraventricular	1	1978	114	0.010	Why?
Hypotension	2	1994	210	0.010	Why?
Azathioprine	1	1978	66	0.010	Why?
Daunorubicin	1	1979	301	0.010	Why?
Pituitary Gland	1	1978	150	0.010	Why?
Selection Bias	1	1997	50	0.010	Why?
Drug Carriers	1	1999	327	0.010	Why?
Medroxyprogesterone Acetate	2	1989	55	0.010	Why?
Amphotericin B	1	1978	289	0.010	Why?
Mice, Nude	1	2005	4307	0.010	Why?
Birth Weight	1	1999	374	0.010	Why?
Liposomes	1	1999	684	0.010	Why?
Tomography, X-Ray Computed	2	2000	7551	0.010	Why?
Minimally Invasive Surgical Procedures	1	2000	500	0.010	Why?
Leukemia, Radiation-Induced	1	1996	24	0.010	Why?
Parathyroid Hormone-Related Protein	1	1996	24	0.010	Why?
Life Tables	1	1996	120	0.010	Why?
Cross-Sectional Studies	1	2006	4314	0.010	Why?
Mouth Diseases	1	1996	34	0.010	Why?
Vaginal Diseases	1	1996	26	0.010	Why?
Complement C4	1	1995	15	0.010	Why?
Isoantigens	1	1995	62	0.010	Why?
Thoracic Neoplasms	1	1979	337	0.010	Why?
Gestational Age	1	1999	1069	0.010	Why?
Fetus	1	1999	601	0.010	Why?
Parathyroid Hormone	1	1996	194	0.010	Why?
Complement C3	1	1995	78	0.010	Why?
Ventricular Function, Left	1	1999	603	0.010	Why?
Complement Activation	1	1995	94	0.010	Why?
Syndrome	1	1978	1351	0.010	Why?
CD4-CD8 Ratio	1	1994	58	0.010	Why?
Infusions, Parenteral	2	1985	191	0.010	Why?
Pleural Effusion	3	1982	201	0.010	Why?
Rats, Inbred F344	1	1994	224	0.010	Why?
Vindesine	2	1985	11	0.010	Why?
Meningeal Neoplasms	1	1978	441	0.010	Why?
Magnesium	1	1994	160	0.010	Why?
Neuromuscular Diseases	1	1994	63	0.010	Why?
Longitudinal Studies	1	1998	1945	0.010	Why?
Vaccination	1	1979	1123	0.010	Why?
Tomography, Emission-Computed, Single-Photon	1	1994	305	0.010	Why?
Leukocyte Count	2	1987	684	0.010	Why?
Decision Making	1	2000	1287	0.010	Why?
Lymphoma	1	1980	1467	0.010	Why?
Indium Radioisotopes	1	1991	65	0.010	Why?
Myocardium	1	1997	1313	0.010	Why?
Muscular Diseases	1	1991	161	0.010	Why?
Nervous System Neoplasms	2	1980	36	0.010	Why?
Pilot Projects	1	1997	2803	0.010	Why?
Tritium	1	1990	200	0.010	Why?
Abortion, Incomplete	1	1990	4	0.010	Why?
Pneumothorax	1	1992	153	0.010	Why?
Propionibacterium acnes	2	1980	25	0.010	Why?
Fluorodeoxyglucose F18	1	1996	1226	0.010	Why?
Enzyme Induction	1	1990	249	0.010	Why?
False Negative Reactions	1	1990	275	0.010	Why?
Electrophoresis	1	1989	60	0.010	Why?
False Positive Reactions	1	1990	355	0.010	Why?
Blotting, Southern	1	1989	406	0.010	Why?
Multiple Myeloma	1	1980	2138	0.010	Why?
Postoperative Complications	1	1984	5542	0.010	Why?
Blotting, Northern	1	1989	682	0.010	Why?
Androgens	2	1983	511	0.010	Why?
Nucleic Acid Hybridization	1	1989	542	0.010	Why?
Vasopressins	1	1988	62	0.000	Why?
Sarcoma	1	1978	1725	0.000	Why?
Peplomycin	1	1987	2	0.000	Why?
Infusions, Intra-Arterial	1	1988	171	0.000	Why?
Proteins	1	1996	1963	0.000	Why?
Immunosorbent Techniques	1	1987	57	0.000	Why?
Sex Factors	1	1992	2139	0.000	Why?
Granulocytes	1	1987	224	0.000	Why?
Accidental Falls	1	1988	142	0.000	Why?
Aspartate Aminotransferases	1	1986	153	0.000	Why?
Tumor Cells, Cultured	1	1994	5395	0.000	Why?
Perfusion	1	1987	293	0.000	Why?
L-Lactate Dehydrogenase	1	1986	299	0.000	Why?
Spine	1	1986	293	0.000	Why?
Mitolactol	1	1984	5	0.000	Why?
Gastrointestinal Neoplasms	2	1980	600	0.000	Why?
DNA, Neoplasm	1	1989	1910	0.000	Why?
Blotting, Western	1	1989	3536	0.000	Why?
Blood Chemical Analysis	1	1983	118	0.000	Why?
Biometry	1	1984	241	0.000	Why?
Cell Line	1	1989	5114	0.000	Why?
Lymphedema	1	1984	239	0.000	Why?
Bence Jones Protein	1	1980	10	0.000	Why?
Myeloma Proteins	1	1980	28	0.000	Why?
Breast	1	1987	1344	0.000	Why?
Respiratory Tract Neoplasms	1	1980	37	0.000	Why?
Global Health	1	1985	657	0.000	Why?
Injections, Intravenous	1	1981	573	0.000	Why?
Gastrointestinal Diseases	1	1985	589	0.000	Why?
Skin Ulcer	1	1980	77	0.000	Why?
Blood Pressure	1	1986	1467	0.000	Why?
Digestive System	1	1979	114	0.000	Why?
Urogenital Neoplasms	1	1980	108	0.000	Why?
Microscopy, Electron	1	1980	600	0.000	Why?
Platelet Count	1	1980	490	0.000	Why?
Drug Therapy	1	1979	205	0.000	Why?
Thyrotropin-Releasing Hormone	1	1978	20	0.000	Why?
Leukocytes	1	1980	422	0.000	Why?
Luteinizing Hormone	1	1978	165	0.000	Why?
Cross Reactions	1	1978	266	0.000	Why?
Prolactin	1	1978	155	0.000	Why?
Heart Neoplasms	1	1980	214	0.000	Why?
Follicle Stimulating Hormone	1	1978	241	0.000	Why?
Echocardiography	1	1983	1182	0.000	Why?
Central Nervous System	1	1979	436	0.000	Why?
Dacarbazine	1	1978	485	0.000	Why?
Diagnostic Errors	1	1980	509	0.000	Why?
Anti-Bacterial Agents	1	1987	2992	0.000	Why?
Brain Neoplasms	2	1979	4849	0.000	Why?
Infant	1	1984	13310	0.000	Why?
Prostatic Neoplasms	1	1985	5767	0.000	Why?
Child, Preschool	1	1984	16273	0.000	Why?
Child	1	1984	29154	0.000	Why?

BUZDAR's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (752)

Explore

Co-Authors (107)

Explore

Similar People (60)

Explore

Same Department

Explore